These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 15207265)

  • 21. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.
    Mantripragada KK; Spurlock G; Kluwe L; Chuzhanova N; Ferner RE; Frayling IM; Dumanski JP; Guha A; Mautner V; Upadhyaya M
    Clin Cancer Res; 2008 Feb; 14(4):1015-24. PubMed ID: 18281533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
    Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
    Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.
    Garza R; Hudson RA; McMahan CA; Walter CA; Vogel KS
    Mutat Res; 2007 Feb; 615(1-2):98-110. PubMed ID: 17208258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Constitutional NF1 mutations in neurofibromatosis 1 patients with malignant peripheral nerve sheath tumors.
    Kluwe L; Friedrich RE; Peiper M; Friedman J; Mautner VF
    Hum Mutat; 2003 Nov; 22(5):420. PubMed ID: 14517963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
    Perrone F; Tabano S; Colombo F; Dagrada G; Birindelli S; Gronchi A; Colecchia M; Pierotti MA; Pilotti S
    Clin Cancer Res; 2003 Sep; 9(11):4132-8. PubMed ID: 14519636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
    Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
    Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.
    Fischer-Huchzermeyer S; Dombrowski A; Hagel C; Mautner VF; Schittenhelm J; Harder A
    Am J Pathol; 2017 Jul; 187(7):1623-1632. PubMed ID: 28502478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
    Ferner RE; Gutmann DH
    Cancer Res; 2002 Mar; 62(5):1573-7. PubMed ID: 11894862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings.
    Spurlock G; Knight SJ; Thomas N; Kiehl TR; Guha A; Upadhyaya M
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1869-80. PubMed ID: 20229272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant peripheral nerve sheath tumors in neurofibromatosis 1.
    King AA; Debaun MR; Riccardi VM; Gutmann DH
    Am J Med Genet; 2000 Aug; 93(5):388-92. PubMed ID: 10951462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization.
    Mechtersheimer G; Otaño-Joos M; Ohl S; Benner A; Lehnert T; Willeke F; Möller P; Otto HF; Lichter P; Joos S
    Genes Chromosomes Cancer; 1999 Aug; 25(4):362-9. PubMed ID: 10398430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofibromatosis 1-associated neuropathies: a reappraisal.
    Drouet A; Wolkenstein P; Lefaucheur JP; Pinson S; Combemale P; Gherardi RK; Brugières P; Salama J; Ehre P; Decq P; Créange A
    Brain; 2004 Sep; 127(Pt 9):1993-2009. PubMed ID: 15289270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
    Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
    Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours.
    Harder A; Rosche M; Reuss DE; Holtkamp N; Uhlmann K; Friedrich R; Mautner VF; von Deimling A
    Eur J Cancer; 2004 Dec; 40(18):2820-8. PubMed ID: 15571966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
    Friedrich RE; Hartmann M; Mautner VF
    Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of Midkine in malignant peripheral nerve sheath tumor cells inhibits apoptosis and increases angiogenic potency.
    Friedrich C; Holtkamp N; Cinatl J; Sakuma S; Mautner VF; Wellman S; Michaelis M; Henze G; Kurtz A; Driever PH
    Int J Oncol; 2005 Nov; 27(5):1433-40. PubMed ID: 16211240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Malignant peripheric nerve sheath tumor of the orbit: first description of orbital location in a patient with NF1].
    Romero-Rojas AE; Díaz-Pérez JA; Lozano-Castillo A
    Neurocirugia (Astur); 2010 Feb; 21(1):37-45. PubMed ID: 20186373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations.
    Carroll SL; Stonecypher MS
    J Neuropathol Exp Neurol; 2004 Nov; 63(11):1115-23. PubMed ID: 15581179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant peripheral nerve sheath tumour of the cervical vagus nerve in a neurofibromatosis type 1 patient.
    Molina AR; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1458-62. PubMed ID: 17113542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
    Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
    Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.